Moderna tops revenue estimates on stronger international COVID vaccine sales
By Julie Steenhuysen May 1 (Reuters) - Moderna surpassed Wall Street estimates for first-quarter revenue on Friday, helped by better-than-expected sales of its COVID-19 vaccine in international markets, sending its shares up nearly 5% in premarket trading. 
